[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"intracerebral-hemorrhage-ich\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:intracerebral-hemorrhage-ich":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100627147","improving-the-prognosis-for-cerebral-hemorrhage-a-study-of-clinical-biological-and-imaging-markers-100627147",false,"NCT07444853","Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers","TIPITCH","Inclusion Criteria:\n\n* Age ≥ 18 years;\n* Emergency admission to a participating center, with spontaneous intracerebral hemorrhage confirmed by the first brain imaging (CT or MRI) performed at the time of initial treatment;\n* Obtaining non-opposition\n\nExclusion Criteria:\n\n* First brain imaging performed outside a center participating in the study (e.g., peripheral center not recruiting);\n* Intracerebral hemorrhage secondary to another identified condition, including:\n\n  * vascular malformation (aneurysm, arteriovenous malformation, cavernoma, etc.);\n  * intracranial tumor;\n  * hemorrhagic transformation of a cerebral infarction;\n  * recent head trauma.\n* Patient under legal protection;\n* Patient under guardianship or conservatorship.","ALL","18 Years",{"count":19,"type":20},10000,"ESTIMATED","2 Years","OBSERVATIONAL","This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected.\n\nThe study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study.\n\nThe cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.",[25],"Intracerebral Hemorrhage (ICH)",[27],"diagnostic and prognostic biomarkers","RECRUITING","2026-04-29",{"date":31,"type":32},"2026-05-06","ACTUAL",{"date":34,"type":32},"2026-04-09",{"date":36,"type":20},"2036-04",{"name":38,"class":39},"University Hospital, Tours","OTHER",4,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":48,"targetDuration":50,"studyType":22,"phases":4,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":53,"whyStopped":4,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":4},"100600641","research-on-the-clinical-value-of-cranial-ct-and-cta-for-cerebral-hemorrhage-patients-100600641","NCT07100132","Research on the Clinical Value of Cranial CT and CTA for Cerebral Hemorrhage Patients","Research on the Clinical Value of Cranial CT and CTA in Patients With Cerebral Hemorrhage","Inclusion Criteria:\n\n(1) Patients who were confirmed to have cerebral hemorrhage through head CT imaging examination upon admission; (2) Those who completed head CT and CTA within 8 hours of onset and had a follow-up CT within 24 hours of admission; (3) With complete clinical data.\n\nExclusion Criteria:\n\n(1) Patients who cannot complete CT and CTA within the prescribed time; (2) Patients with secondary cerebral hemorrhage due to cerebral vascular malformations, brain tumors, brain trauma, cerebral aneurysms, etc.; (3) Patients who have been taking oral anticoagulants for a long time or have blood system diseases; (4) Primary intraventricular hemorrhage.",{"count":49,"type":20},300,"6 Months","The objective of this observational study is to investigate the predictive value of various imaging signs in patients with intracerebral hemorrhage, thereby providing a reference for clinical diagnosis and treatment. The primary aim is to evaluate the association between specific imaging signs and both hematoma expansion and poor outcomes in these patients.",[25],"NOT_YET_RECRUITING","2025-07-27",{"date":56,"type":32},"2025-08-03",{"date":58,"type":20},"2025-10-01",{"date":60,"type":20},"2027-06-01",{"name":62,"class":39},"The Affiliated Hospital Of Guizhou Medical University"]